212 related articles for article (PubMed ID: 1283768)
21. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
Julius S
Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
[TBL] [Abstract][Full Text] [Related]
22. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
[TBL] [Abstract][Full Text] [Related]
23. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
24. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
[TBL] [Abstract][Full Text] [Related]
25. High blood pressure management: potential benefits of I1 agents.
Esler M
J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
[TBL] [Abstract][Full Text] [Related]
26. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
Hodge AM; Dowse GK; Zimmet PZ
Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
[TBL] [Abstract][Full Text] [Related]
27. Carbohydrate metabolism, insulin resistance, and metabolic cardiovascular syndrome.
Vaaler S
J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S11-4. PubMed ID: 1283763
[TBL] [Abstract][Full Text] [Related]
28. Sympathetic neural activity in hypertension and related diseases.
Grassi G
Am J Hypertens; 2010 Oct; 23(10):1052-60. PubMed ID: 20651696
[TBL] [Abstract][Full Text] [Related]
29. [Metabolic disturbances as a factor of the pathogenesis of hypertensive disease and its clinical outcomes].
Kovalenko VN; Talayeva TV; Shumakov VA; Bratus VV
Ter Arkh; 2012; 84(11):51-8. PubMed ID: 23252248
[TBL] [Abstract][Full Text] [Related]
30. The contribution of the sympathoadrenomedullary system to the etiology of essential hypertension: a study using plasma and platelet catecholamine concentrations.
Carstensen E; Ramaiya K; Denver E; Mohamed-Ali V; Yudkin JS
J Clin Endocrinol Metab; 1995 Feb; 80(2):455-60. PubMed ID: 7852504
[TBL] [Abstract][Full Text] [Related]
31. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web.
DeFronzo RA
J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S1-16. PubMed ID: 1284137
[TBL] [Abstract][Full Text] [Related]
32. Role of catecholamines in platelet function: pathophysiological and clinical significance.
Anfossi G; Trovati M
Eur J Clin Invest; 1996 May; 26(5):353-70. PubMed ID: 8796362
[TBL] [Abstract][Full Text] [Related]
33. Abdominal fat and sympathetic overactivity. From calorie intake to postmenopausal hypertension.
Rupp H; Maisch B
Herz; 2003 Dec; 28(8):668-73. PubMed ID: 14689100
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance and sympathetic overactivity in women.
Kaaja RJ; Pöyhönen-Alho MK
J Hypertens; 2006 Jan; 24(1):131-41. PubMed ID: 16331111
[TBL] [Abstract][Full Text] [Related]
35. Insulin resistance and the sympathetic nervous system.
Egan BM
Curr Hypertens Rep; 2003 Jun; 5(3):247-54. PubMed ID: 12724058
[TBL] [Abstract][Full Text] [Related]
36. Stress and cardiovascular disease.
Eliot RS
Eur J Cardiol; 1977 Mar; 5(2):97-104. PubMed ID: 15843
[TBL] [Abstract][Full Text] [Related]
37. Normal pancreastatin-like and increased post-glucose insulin levels in young offspring of insulin-resistant non-obese essential hypertensive patients.
Sánchez-Margalet V; Ramos E; Mateo J; Oliván J; Pérez-Cano R; Goberna R
J Endocrinol; 1997 May; 153(2):313-8. PubMed ID: 9166122
[TBL] [Abstract][Full Text] [Related]
38. [The sympathetic nervous system and insulin resistance].
Rosolová H
Vnitr Lek; 2003 Jan; 49(1):61-5. PubMed ID: 12666435
[TBL] [Abstract][Full Text] [Related]
39. Stress and metabolism.
Seematter G; Binnert C; Tappy L
Metab Syndr Relat Disord; 2005; 3(1):8-13. PubMed ID: 18370704
[TBL] [Abstract][Full Text] [Related]
40. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension.
Huggett RJ; Burns J; Mackintosh AF; Mary DA
Hypertension; 2004 Dec; 44(6):847-52. PubMed ID: 15520303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
